Condition
Heart Transplant clinical trials and research
As of November 12, 2026, Find a Trial lists 11 Heart Transplant clinical trials that are recruiting, at sites in 4 countries (most in United States (8), China (1), Canada (1)). By phase: Phase 3 (2), Phase 4 (1), Phase 2 (1). There are also 9 NIH-funded research projects on Heart Transplant, with $7.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 11Clinical trials
- 9NIH research projects
- 4Countries
Newest Heart Transplant clinical trials
All recruiting trials (11)
-
Non-invasive test to predict early heart rejection in pediatric transplant patients
This study tests non-invasive heart tests like cardiac MRI and blood markers to see if they can detect rejection in kids after heart transplant, potentially reducing the need for invasive biopsies.
-
Non-intubated anesthesia for adult heart transplantation
This trial tests whether keeping patients breathing on their own with a supraglottic airway during heart transplantation leads to fewer complications and faster recovery compared with standard intubated anesthesia.
-
Apixaban vs Warfarin in HeartMate 3 LVAD Patients
This study tests whether apixaban can replace warfarin to prevent clots and bleeding problems in adults with an implanted HeartMate 3 LVAD for at least 3 months.
-
Improving donor heart preservation with the OCS Heart System
This study will test whether the OCS Heart System with a new preservation solution and a functional enhancer helps donor hearts—including DCD and higher‑risk DBD hearts—stay healthier and improve transplant outcomes compared with standard cold storage.
-
XVIVO Heart Box non-ischemic preservation for transporting donor hearts.
This program tests whether the XVIVO non-ischemic heart preservation system can safely preserve extended-criteria donor hearts for adults waiting for a heart transplant.
-
Empagliflozin to protect kidney and heart health after heart transplant
This trial will test whether empagliflozin can protect kidney and heart health and improve metabolic and functional outcomes in Veterans who have had a heart transplant.
-
Using belatacept for heart transplant patients
This study is testing if a new medication called belatacept can safely help heart transplant patients avoid rejection and complications compared to the usual treatment.
-
Effects of resistance training for patients waiting for heart transplants
This study tests if a resistance training program can help heart failure patients waiting for a transplant feel better and improve their overall health.
-
Registry for heart transplant outcomes using OCS Heart System
This study tracks how well the OCS Heart System works for preserving donor hearts in heart transplant patients over five years to see if it helps them do better after surgery.
-
Exercise, lung, and heart fitness in young survivors of heart transplant, childhood leukemia, and premature lung disease
This project tests non-invasive exercise and breathing tests to see how well 8–25-year-olds who survived childhood leukemia, were born with chronic lung disease of prematurity, or had a heart transplant tolerate and perform during physical activity.
-
Investigating antiplatelet therapy to prevent complications in heart transplant patients
This study tests if giving heart transplant patients early treatment with aspirin or clopidogrel can help prevent a common problem where their heart arteries narrow.
NIH-funded research (9)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Pediatric Heart Pump to Let Kids Go Home While Waiting for Transplant
A new ultra-low-power pediatric heart pump is being developed so children awaiting a heart transplant can go home or live with the device.
-
Predicting acute rejection in children after heart transplant
A study to improve how doctors predict if a child who has had a heart transplant will have acute rejection using noninvasive blood markers and advanced heart MRI analysis.
-
Molecular mismatch as a marker of immune risk in heart transplant patients
A study to see if specific biological differences between donor and recipient hearts can predict immune reactions and guide personalized immunosuppression in people who receive heart transplants.
-
Fair and efficient heart transplant allocation using AI-powered continuous distribution
A NIH-funded project will develop fair and efficient computer-based methods to match donated hearts with patients needing transplants.
-
Better ways to find heart transplant rejection in children
This research aims to find less invasive and more accurate ways to detect when a child's body is rejecting a new heart.
-
Investigating a medication to protect kidney function in heart transplant patients
This study is looking at whether a medication called empagliflozin can help improve kidney health and overall well-being in heart transplant patients who are at risk for kidney and heart problems, and we're inviting Veterans to join us in this important research.
-
Discovering biomarkers to improve heart transplant outcomes
This study is looking at how new technologies can help find important signs in heart transplant patients to better predict and manage issues like rejection, so that doctors can provide more personalized care and improve recovery for those patients.
-
Improving detection of acute rejection in children who have heart transplants
This study is looking for safer ways to check for heart transplant rejection in kids by using blood tests and special imaging instead of needing risky biopsies, helping to keep young patients healthier and more comfortable.
-
Using a mobile app to help young heart transplant patients take their medications
This study is looking at whether a mobile app that helps teens who have had a heart transplant remember to take their medications works better than regular check-ins with doctors, to see which way helps them stay healthy and feel better overall.
Related topics
Quick answers
How many Heart Transplant clinical trials are recruiting right now?
11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (8 trials), China (1 trial), Canada (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.